However, only a small number of patients actually benefit from extended endocrine therapy, and those benefits come at the risk for adverse events highlighting the need for prognostic and predictive biomarkers that can assess the risk for late recurrence and identify those patients who are most likely to benefit from the extended therapy <a href=https://cialiss.skin>best site to buy cialis online</a> Despite this there is no scientific evidence that Anastrozol 1MG can be dangerous for healthy individuals to use, even for extended periods of time